Impact of Conditioning Intensity on Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Patients with Acute Leukemia and Myelodysplastic Syndromes

被引：0
|
作者：
Shahzad, Moazzam [1 ]
Amin, Muhammad Kashif [1 ,2 ,3 ,4 ]
Rehman, Aqeeb Ur [1 ,3 ]
Mohsin, Aleenah [1 ,3 ]
Mcguirk, Matthew [1 ,3 ]
Chaudhary, Sibgha Gull [1 ,3 ,4 ]
Anwar, Iqra [1 ,3 ]
Abdelhakim, Haitham [1 ,5 ]
Singh, Anurag K. [1 ,3 ,4 ]
Hamadani, Mehdi [1 ,6 ]
Mcguirk, Joseph P. [1 ,3 ,4 ]
Mushtaq, Muhammad Umair [3 ,4 ,7 ]
机构：
[1] Mikael Rayaan Fdn Global Hlth Consortium, Kansas City, KS USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Oncol Sci, Tampa, FL USA
[3] Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Kansas City, KS USA
[4] US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA
[5] Univ Kansas, Canc Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA
[6] Med Coll Wisconsin Inc, Div Hematol & Oncol, Milwaukee, WI USA
[7] MRF, Kansas City, KS USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-199436
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4860 / 4861
页数：2
相关论文
共 50 条
  • [21] Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Patients with Acute Erythroleukemia
    Alkhateeb, Hassan B.
    Damlaj, Moussab
    Hefazi, Mehrdad
    Dias, Ajoy
    Hashmi, Shahrukh K.
    Hogan, William J.
    Litzow, Mark R.
    Patnaik, Mrinal S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S195 - S196
  • [22] Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia
    Nagler, Arnon
    Peczynski, Christophe
    Dholaria, Bhagirathbhai
    Labopin, Myriam
    Valerius, Thomas
    Dreger, Peter
    Kroeger, Nicolaus
    Reinhardt, Hans Christian
    Finke, Juergen
    Franke, Georg-Nikolaus
    Ciceri, Fabio
    Verbeek, Mareike
    Blau, Igor Wolfgang
    Bornhaeuser, Martin
    Spyridonidis, Alexandros
    Bug, Gesine
    Bazarbachi, Ali
    Schmid, Christophe
    Yakoub-Agha, Ibrahim
    Savani, Bipin N.
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2022, 57 (07) : 1116 - 1123
  • [23] Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia
    Arnon Nagler
    Christophe Peczynski
    Bhagirathbhai Dholaria
    Myriam Labopin
    Thomas Valerius
    Peter Dreger
    Nicolaus Kröger
    Hans Christian Reinhardt
    Jürgen Finke
    Georg-Nikolaus Franke
    Fabio Ciceri
    Mareike Verbeek
    Igor Wolfgang Blau
    Martin Bornhäuser
    Alexandros Spyridonidis
    Gesine Bug
    Ali Bazarbachi
    Christophe Schmid
    Ibrahim Yakoub-Agha
    Bipin N. Savani
    Mohamad Mohty
    Bone Marrow Transplantation, 2022, 57 : 1116 - 1123
  • [24] A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes
    Nazha, Aziz
    Hu, Zhen-Huan
    Wang, Tao
    Lindsley, R. Coleman
    Abdel-Azim, Hisham
    Aljurf, Mahmoud
    Bacher, Ulrike
    Bashey, Asad
    Cahn, Jean-Yves
    Cerny, Jan
    Copelan, Edward
    DeFilipp, Zachariah
    Diaz, Miguel Angel
    Farhadfar, Nosha
    Gadalla, Shahinaz M.
    Gale, Robert Peter
    George, Biju
    Gergis, Usama
    Grunwald, Michael R.
    Hamilton, Betty
    Hashmi, Shahrukh
    Hildebrandt, Gerhard C.
    Inamoto, Yoshihiro
    Kalaycio, Matt
    Kamble, Rammurti T.
    Kharfan-Dabaja, Mohamed A.
    Lazarus, Hillard M.
    Liesveld, Jane L.
    Litzow, Mark R.
    Majhail, Navneet S.
    Murthy, Hemant S.
    Nathan, Sunita
    Nishihori, Taiga
    Pawarode, Attaphol
    Rizzieri, David
    Sabloff, Mitchell
    Savani, Bipin N.
    Schachter, Levanto
    Schouten, Harry C.
    Seo, Sachiko
    Shah, Nirav N.
    Solh, Melhem
    Valcarcel, David
    Vij, Ravi
    Warlick, Erica
    Wirk, Baldeep
    Wood, William A.
    Yared, Jean A.
    Alyea, Edwin
    Popat, Uday
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (11) : 2139 - 2146
  • [25] Impact of the Intensity of Conditioning Therapy On the Outcomes of Patients Aged 40 to 60 Years with Acute Myeloid Leukemia/Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Al-Khabori, Murtadha K.
    El-Emary, Mohamed
    Guyatt, Gordon
    Galal, Ahmed
    Kuruvilla, John
    Lipton, Jeffrey H.
    Messner, Hans A.
    Gupta, Vikas
    BLOOD, 2009, 114 (22) : 494 - 494
  • [26] Correction to: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality
    A. Sutra Del Galy
    A. Marouf
    E. Raffoux
    M. Robin
    D. Michonneau
    M. Sébert
    F. Sicre de Fontebrune
    A. Xhaard
    E. Lengline
    R. Itzykson
    C. Frieri
    H. Dombret
    P. Fenaux
    R. Peffault de Latour
    L. Adès
    G. Socié
    Leukemia, 2021, 35 : 934 - 934
  • [27] Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Metheny, Leland, III
    Saber, Wael
    Weisdorf, Daniel J.
    de Lima, Marcos
    Callander, Natalie Scott
    Litzow, Mark
    Kebriaei, Partow
    Hall, Aric C.
    Sandmaier, Brenda M.
    Zhang, Mei-Jie
    Wang, Hai-Lin
    Bo-Subait, Khalid
    BLOOD, 2019, 134
  • [28] Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
    Lekakis, Lazaros
    de Lima, Marcos
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 785 - 798
  • [29] FAVORABLE OUTCOMES OF REDUCED-INTENSITY CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH ACUTE LEUKEMIA
    Koh, K.
    Seo, J.
    Choi, E.
    Im, H.
    Seo, J.
    HAEMATOLOGICA, 2013, 98 : 663 - 663
  • [30] Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia
    Dhere, Vishal
    Edelman, Scott
    Waller, Edmund K.
    Langston, Amelia
    Graiser, Michael
    Connolly, Erin C.
    Switchenko, Jeffrey M.
    Esiashvili, Natia
    Khan, Mohammad K.
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 837 - 843
12345